Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin injection before axillary node dissection to reduce lymphorrhea in breast cancer surgery
2015-004337-27Phase 2Completed
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of octreotide in breast cancer, sponsored by Institut Cancérologique de l'Ouest. Primary endpoint: Lymphorrhea requiring at least one puncture. Started Jun 2016; status: completed.
02
Drugs
octreotide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2015-004337-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004337-27.